Tychan Begins Phase I Clinical Trial for Monoclonal Antibody Treatment against COVID-19
Singapore-based clinical-stage biotechnology company, Tychan, completes recruitment and starts Phase I clinical trial of monoclonal antibody specifically targeting SARS-CoV-2. In mid-June 2020,...